» Articles » PMID: 16263947

Wheeze, Asthma Diagnosis and Medication Use: a National Adult Survey in a Developing Country

Overview
Journal Thorax
Date 2005 Nov 3
PMID 16263947
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As relatively little is known about adult wheeze and asthma in developing countries, this study aimed to determine the predictors of wheeze, asthma diagnosis, and current treatment in a national survey of South African adults.

Methods: A stratified national probability sample of households was drawn and all adults (>14 years) in the selected households were interviewed. Outcomes of interest were recent wheeze, asthma diagnosis, and current use of asthma medication. Predictors of interest were sex, age, household asset index, education, racial group, urban residence, medical insurance, domestic exposure to smoky fuels, occupational exposure, smoking, body mass index, and past tuberculosis.

Results: A total of 5671 men and 8155 women were studied. Although recent wheeze was reported by 14.4% of men and 17.6% of women and asthma diagnosis by 3.7% of men and 3.8% of women, women were less likely than men to be on current treatment (OR 0.6; 95% confidence interval (CI) 0.5 to 0.8). A history of tuberculosis was an independent predictor of both recent wheeze (OR 3.4; 95% CI 2.5 to 4.7) and asthma diagnosis (OR 2.2; 95% CI 1.5 to 3.2), as was occupational exposure (wheeze: OR 1.8; 95% CI 1.5 to 2.0; asthma diagnosis: OR 1.9; 95% CI 1.4 to 2.4). Smoking was associated with wheeze but not asthma diagnosis. Obesity showed an association with wheeze only in younger women. Both wheeze and asthma diagnosis were more prevalent in those with less education but had no association with the asset index. Independently, having medical insurance was associated with a higher prevalence of diagnosis.

Conclusions: Some of the findings may be to due to reporting bias and heterogeneity of the categories wheeze and asthma diagnosis, which may overlap with post tuberculous airways obstruction and chronic obstructive pulmonary disease due to smoking and occupational exposures. The results underline the importance of controlling tuberculosis and occupational exposures as well as smoking in reducing chronic respiratory morbidity. Validation of the asthma questionnaire in this setting and research into the pathophysiology of post tuberculous airways obstruction are also needed.

Citing Articles

A model-based approach to estimating the prevalence of disease combinations in South Africa.

Johnson L, Kassanjee R, Folb N, Bennett S, Boulle A, Levitt N BMJ Glob Health. 2024; 9(2).

PMID: 38388163 PMC: 10884267. DOI: 10.1136/bmjgh-2023-013376.


Urinary metabolites of polycyclic aromatic hydrocarbons and short-acting beta agonist or systemic corticosteroid asthma medication use within NHANES.

Uong S, Hussain H, Thanik E, Lovinsky-Desir S, Stingone J Environ Res. 2022; 220:115150.

PMID: 36572332 PMC: 9969867. DOI: 10.1016/j.envres.2022.115150.


Chronic diseases of lifestyle risk factor profiles of a South African rural community.

Akindele M, Useh U J Public Health Afr. 2021; 12(1):1006.

PMID: 34249292 PMC: 8239450. DOI: 10.4081/jphia.2021.1006.


Prevalence of chronic respiratory disease in urban and rural Uganda.

Siddharthan T, Grigsby M, Morgan B, Kalyesubula R, Wise R, Kirenga B Bull World Health Organ. 2019; 97(5):318-327.

PMID: 31551628 PMC: 6747035. DOI: 10.2471/BLT.18.216523.


Urbanisation and asthma in low-income and middle-income countries: a systematic review of the urban-rural differences in asthma prevalence.

Rodriguez A, Brickley E, Rodrigues L, Normansell R, Barreto M, Cooper P Thorax. 2019; 74(11):1020-1030.

PMID: 31278168 PMC: 6860411. DOI: 10.1136/thoraxjnl-2018-211793.


References
1.
Menezes A, Victora C, RIGATTO M . Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study. Thorax. 1994; 49(12):1217-21. PMC: 475326. DOI: 10.1136/thx.49.12.1217. View

2.
Burney P, Laitinen L, Perdrizet S, Huckauf H, Tattersfield A, Chinn S . Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J. 1989; 2(10):940-5. View

3.
Janson C, Chinn S, Jarvis D, Burney P . Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J. 1997; 10(8):1795-802. DOI: 10.1183/09031936.97.10081795. View

4.
Saraclar Y, Cetinkaya F, Tuncer A, Kalayci O, Adalioglu G, Sekerel B . The prevalence of self-reported asthma and respiratory symptoms in Ankara, Turkey. Respir Med. 1997; 91(8):461-3. DOI: 10.1016/s0954-6111(97)90110-4. View

5.
Chowgule R, Shetye V, Parmar J, Bhosale A, Khandagale M, Phalnitkar S . Prevalence of respiratory symptoms, bronchial hyperreactivity, and asthma in a megacity. Results of the European community respiratory health survey in Mumbai (Bombay). Am J Respir Crit Care Med. 1998; 158(2):547-54. DOI: 10.1164/ajrccm.158.2.9708064. View